NCT00960245View on ClinicalTrials.gov

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 1994

Primary Completion Date

July 31, 1994

Study Completion Date

July 31, 1994

Conditions
High Blood PressureMigraine HeadachesChest Pain
Interventions
DRUG

Nadolol (1 x 80 mg) Tablets (Invamed, Inc)

DRUG

Corgard (1 x 80 mg) Tablets (Bristol Laboratories)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00960245 - Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter